Outbreak of Shigella sonnei gastroenteritis in Northeastern Taiwan

Pediatric Infectious Disease Journal

Volumn 25, Issue 1, 2006, Pages 92-94

  Chuang, Yu Yu ^a   Huang, Yhu Chering ^b   Lin, Seng Yi ^a  

^a St Mary's Hospital   (Taiwan)

^b CHANG GUNG CHILDREN S HOSPITAL   (Taiwan)

Author keywords

Outbreak; Shigella flexneri; Shigella sonnei; Shigellosis; Taiwan

Indexed keywords

AMPICILLIN; CEFIXIME; CEFTAZIDIME; CEFTRIAXONE; CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN; MEROPENEM; NALIDIXIC ACID; NORFLOXACIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL STRAIN; BACTERIUM CULTURE; CHILD; EPIDEMIC; FECES; FEMALE; GASTROENTERITIS; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SHIGELLA FLEXNERI; SHIGELLA SONNEI; SHIGELLOSIS; TAIWAN;

ADOLESCENT; ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; DYSENTERY, BACILLARY; FECES; FEMALE; GASTROENTERITIS; HUMANS; INFANT; INFANT, NEWBORN; MALE; MICROBIAL SENSITIVITY TESTS; SHIGELLA SONNEI; TAIWAN;

EID: 33644848265     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.inf.0000198747.54971.b2     Document Type: Article

References (15)

1. Sivapalasingam S, McClellan J, Joyce K, et al. Increasing antimicrobial resistance among Shigella isolates in the United States, 1999-2000. Presented at the 39th Annual Meeting of the Infectious Diseases Society of America, October 25-28, 2001, San Francisco, CA.
2. Ashkenazi S, Levy I, Kazaronovski V, Samra Z. Growing antimicrobial resistance of Shigella isolates. J Antimicrob Chemother. 2003;51:427-429.
3. Oh JY, Yu HS, Kim SK, Seol SY, Cho DT, Lee JC. Changes in patterns of antimicrobial susceptibility and integron carriage among Shigella sonnei isolates from Southwestern Korea during epidemic periods. J Clin Microbiol. 2003;41:421-423.
4. Isenbarger DW, Hoge CW, Srijan A, et al. Comparative antibiotic resistance of diarrheal pathogens from Vietnam and Thailand, 1996-1999. Emerg Infect Dis. 2002;8:175-180.
5. Replogle ML, Fleming DW, Chieslak PR. Emergence of antimicrobial- resistant shigellosis in Oregon. Clin Infect Dis. 2000;30:515-519.
6. Aysev AD, Guriz H. Drug resistance of Shigella strains isolated in Ankara Turkey, 1993-1996. Scand J Infect Dis. 1998;30:351-353.
7. Gaudreau C, Turgeon P. Antibiotic resistance of Shigella spp., Salmonella spp., and Yersinia spp. isolated in Quebec. Can Communicable Dis Rep. 1997;23:57-59.
8. Maraki S, Georgiladakis A, Christidou A, Scoulica E, Tselentis Y. Antimicrobial susceptibilities and β-lactamase production of Shigella isolates in Crete, Greece, during the period 1991-1995. APMIS. 1998;106:879-883.
9. Department of Health, Taiwan, R.O.C. Statistically important characteristics in public health in Taiwan, Republic of China. Taipei, Taiwan: Republic of China Department of Health; 2002.
10. National Committee for Clinical Laboratory Standards. Performance Standards for Antimicrobial Disk Susceptibility Tests: Approved Standard M2-A7. Villanova, PA: National Committee for Clinical Laboratory Standards; 2000.
11. Bennish ML, Salam MA. Rethinking the options for treatment of shigellosis. J Antimicrob Chemother. 1992;30:243-247.
12. Hampel B, Hullmann R, Schmidt H. Ciprofloxacin in pediatrics: worldwide clinical experience based on compassionate use: safety report. Pediatr Infect Dis J. 1997;16:127-129.
13. Jick S. Ciprofloxacin safety in a pediatric population. Pediatr Infect Dis J. 1997;16:130-134.
14. Bhattacharya SK, Bhattacharya MK, Dutta D, et al. Double-blind, randomized clinical trial for safety and efficacy of norfloxacin for shigellosis in children. Acta Paediatr. 1997;86:319-320.
15. Green S, Tillotson G. Use of ciprofloxacin in developing countries. Pediatr Infect Dis J. 1997;16:150-159.